Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details attached herewith.
29-03-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Intimation Of Incorporation Of A Wholly Owned Subsidiary Company In Ireland

This is in continuation to our letter dated February 09, 2022 and pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we hereby inform that the Company has incorporated a Company namely 'GUFIC IRELAND LIMITED' with the intent of making it Wholly Owned Subsidiary of the Company. The details as required under Regulation 30 of SEBI Listing Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is attached herewith.
04-03-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

This is in continuation to our communication dated February 20, 2023 on Earnings Conference Call and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, written transcript of the said call held on February 20, 2023 at 4:30 p.m., has been uploaded on the Company's website which can be accessed through the link: http://gufic.com/Notice/WrittenTranscript_200223.pdf
24-02-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on February 20, 2023 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_20022023.mp3 Written transcript of the same will be submitted in due course.
20-02-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company will host an Earnings Conference Call for Investors/Analysts on Monday, February 20, 2023, at 4:30 p.m. (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. The details of the Earnings Conference Call are mentioned in the Call Invite enclosed herewith.
15-02-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Outcome for Meeting Held On Friday, February 10, 2023

Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. Friday, February 10, 2023, inter alia, considered and approved: 1. The Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report thereon. Copies of the same are enclosed herewith. 2. Re-appointment of M/s. Manish Ghia & Associates, Practicing Company Secretaries, Mumbai as the Secretarial Auditor of the Company to conduct Secretarial Audit of the Company for the Financial year 2022 -23 and issue report thereon. Disclosure pursuant to SEBI Circular No. CIR/CFD/ CMD/4/2015 dated 9th September, 2015 is enclosed herewith.
10-02-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Results -Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022

Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. Friday, February 10, 2023, inter alia, considered and approved: 1. The Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report thereon. Copies of the same are enclosed herewith. 2. Re-appointment of M/s. Manish Ghia & Associates, Practicing Company Secretaries, Mumbai as the Secretarial Auditor of the Company to conduct Secretarial Audit of the Company for the Financial year 2022 -23 and issue report thereon. The meeting of the Board of Directors commenced at 4:30 p.m. and concluded at 6:15 p.m.
10-02-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2022

GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. Further in continuation to our disclosure on Closure of Trading Window dated December 29, 2022 and pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window in respect of dealing in the Equity Shares of the Company for all the Designated Persons of the Company along with their immediate relatives, shall continue to remain closed until 48 hours post declaration of the said financial results.
02-02-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements Regulations), 2015, the Company has received information from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company ('RTA'), regarding the duplicate share certificates of the Company that have been issued, in lieu of the original having been lost/misplaced, the details of which are enclosed herewith. Pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25, 2022 a letter of confirmation in this regard, will be issued to the aforementioned shareholder upon completion of required formalities.
31-01-2023
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith the letter received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended December 31, 2022.
11-01-2023
Next Page
Close

Let's Open Free Demat Account